LipoScan identifies and differentiates all cholesterol particles quantitively by their size. It also differentiates the highly atherogenic, small, dense LDL and IDL from the large, less atherogenic LDL and VLDL and protective HDL. This test is indicated for the screening, management and monitoring of lipid disorders and symptoms associated with cardiovascular disease. Alongside this, Oxidated LDL is a good predictor of cardiovascular health risks. Low density lipoprotein (LDL) can become oxidised when it reacts with free radicals in the body. When oxidised, LDL is less stable and more likely to cause damage to endothelial tissue that lines blood vessels. The resulting inflammatory response and formation of arteriosclerotic plaques can lead to a variety of cardiovascular symptoms and conditions. This combined panel may be helpful for those with a diagnosis or family history of cardiovascular disease, type 2 diabetes, metabolic syndrome, obesity or imbalanced blood markers relating to cholesterol, blood glucose and triglycerides.
